TP53 and cancer: P21, the downstream gene of p53, functions as a regulator of cell cycle progression by binding to CDK/cyclin complexes, is associated with testicular cancer andovarian cancer resistance to cisplatin chemotherapy [51–53], and itsincreased expression is also associated with PCa cells docetaxel resistance [19, 54].